Quality-by-Design III: Application of Near-Infrared Spectroscopy to Monitor Roller Compaction In-process and Product Quality Attributes of Immediate Release Tablets
暂无分享,去创建一个
[1] K. A. Khan,et al. Effect of Re-Compression on the Properties of Tablets Prepared by Moist Granulation , 1983 .
[2] R C Rowe,et al. The effect of punch velocity on the compaction of a variety of materials , 1985, The Journal of pharmacy and pharmacology.
[3] J. Remon,et al. Roller compaction and tableting of microcrystalline cellulose/drug mixtures , 1998 .
[4] Colleen E. Ruegger,et al. The Effect of Compression and Decompression Speed on the Mechanical Strength of Compacts , 2000, Pharmaceutical development and technology.
[5] K. Morris,et al. Real-time near-infrared monitoring of content uniformity, moisture content, compact density, tensile strength, and Young's modulus of roller compacted powder blends. , 2005, Journal of pharmaceutical sciences.
[6] K. Morris,et al. Influence of ambient moisture on the compaction behavior of microcrystalline cellulose powder undergoing uni-axial compression and roller-compaction: a comparative study using near-infrared spectroscopy. , 2005, Journal of pharmaceutical sciences.
[7] Changquan Calvin Sun,et al. Reduced tabletability of roller compacted granules as a result of granule size enlargement. , 2006, Journal of pharmaceutical sciences.
[8] F. Rinaldi,et al. Effect of hydroxypropyl cellulose (HPC) on dissolution rate of hydrochlorothiazide tablets. , 2006, International journal of pharmaceutics.
[9] P. Bertelsen,et al. Improving the compaction properties of roller compacted calcium carbonate. , 2007, International journal of pharmaceutics.
[10] K. Morris,et al. Importance of Raw Material Attributes for Modeling Ribbon and Granule Properties in Roller Compaction: Multivariate Analysis on Roll Gap and NIR Spectral Slope as Process Critical Control Parameters , 2007, Journal of Pharmaceutical Innovation.
[11] Investigation of Serrated Roll Surface Differences on Ribbon Thickness During Roller Compaction , 2007, Pharmaceutical development and technology.
[12] R. Fahmy,et al. Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms , 2005, AAPS PharmSciTech.
[13] Stephen W Hoag,et al. Quality by design, part I: application of NIR spectroscopy to monitor tablet manufacturing process. , 2008, Journal of pharmaceutical sciences.
[14] Stephen W Hoag,et al. Quality by design, part II: application of NIR spectroscopy to monitor the coating process for a pharmaceutical sustained release product. , 2008, Journal of pharmaceutical sciences.
[15] Hong Wen,et al. Systematical approach of formulation and process development using roller compaction. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] Stuart L. Cantor,et al. NIR Spectroscopy Applications in the Development of a Compacted Multiparticulate System for Modified Release , 2011, AAPS PharmSciTech.
[17] D. Barends,et al. Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride. , 2011, Journal of pharmaceutical sciences.
[18] Vivek S. Dave,et al. Assessment of the critical factors affecting the porosity of roller compacted ribbons and the feasibility of using NIR chemical imaging to evaluate the porosity distribution. , 2011, International journal of pharmaceutics.
[19] Ravikanth Kona,et al. Quality by Design I: Application of Failure Mode Effect Analysis (FMEA) and Plackett–Burman Design of Experiments in the Identification of “Main Factors” in the Formulation and Process Design Space for Roller-Compacted Ciprofloxacin Hydrochloride Immediate-Release Tablets , 2012, AAPS PharmSciTech.
[20] R. Fahmy,et al. Eudragit® RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets , 2012, Drug development and industrial pharmacy.
[21] Stephen W. Hoag,et al. Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets , 2015, AAPS PharmSciTech.